Nelofar Barlas, PA

Offices

1 location · Stanford Health Care · 3,152 clinicians in this group

Looking this up.

Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.

Plan participation

Not verified

We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Nelofar Barlas’s office at (650) 723-4000 to ask if they take your plan before you enroll.

Hospitals they work in

1 hospital

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend it
Overall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024

See every measure and the patient survey for Stanford Health Care

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Sort by

Every scored measure at Stanford Health Care

Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths	5.31 (4.24 to 6.37) · 8,661 cases	Worse	Jul 2022 – Jun 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits	14.1 (12.7 to 15.7) · 2,191 cases	Worse	Jan 2024 – Dec 2024
Postoperative respiratory failure rateComplications and deaths	4.08 (1.95 to 6.21) · 5,296 cases	Better	Jul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections	0.317	Better	Oct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections	0.446	Better	Oct 2024 – Sep 2025
SSI - Colon SurgeryInfections	0.241	Better	Oct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits	0.7 (0.6 to 0.9) · 3,348 cases	Better	Jan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths	1.06 (0.45 to 1.67) · 5,374 cases	No different	Jul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths	0.86 (0.72 to 1)	No different	Jul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths	166.09 (137.88 to 194.3) · 470 cases	No different	Jul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths	1.1 · 192 cases	None	Jul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths	6.4 · 146 cases	None	Jul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths	9.7 · 253 cases	None	Jul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths	6.3 · 880 cases	None	Jul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths	10.3 · 935 cases	None	Jul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths	8.7 · 501 cases	None	Jul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths	2.1 · 7,730 cases	None	Jul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths	0.13 (0 to 0.27) · 20,799 cases	No different	Jul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths	0.28 (0.14 to 0.43) · 23,182 cases	No different	Jul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths	0.94 (0.2 to 1.68) · 5,694 cases	No different	Jul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths	2.36 (1.54 to 3.19) · 7,846 cases	No different	Jul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths	5.2 (3.76 to 6.64) · 5,603 cases	No different	Jul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths	1.38 (0.23 to 2.53) · 2,211 cases	No different	Jul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths	0.52 (0.21 to 0.83) · 19,915 cases	No different	Jul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths	3.6 · 416 cases	None	Apr 2023 – Mar 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections	0.869	No different	Oct 2024 – Sep 2025
MRSA BacteremiaInfections	0.857	No different	Oct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections	0.368	No different	Oct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits	16.2 · 247 cases	None	Jul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits	20.5 · 1,021 cases	None	Jul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits	47.8 · 258 cases	None	Jul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits	-1.6 · 990 cases	None	Jul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits	20.8 · 976 cases	None	Jul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits	16.5 · 959 cases	None	Jul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits	5.2 (4.4 to 6.2) · 2,191 cases	No different	Jan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits	5.1 · 425 cases	None	Jul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits	9.6 · 158 cases	None	Jul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits	19.6 · 183 cases	None	Jul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits	12.7 (10.4 to 15.4) · 4,578 cases	No different	Jan 2022 – Dec 2024

What patients said (6,810 patients answered, 25% of those asked)

Sort by

Patient survey stars by topic at Stanford Health Care

Cleanliness	4
Nurse communication	4
Doctor communication	4
Communication about medicines	3
Discharge information	4
Overall hospital rating	4
Quietness	2
Recommend hospital	5

Sort by

Share of patients giving the best answer at Stanford Health Care

Room was "always" clean	75%
Nurses "always" communicated well	82%
Doctors "always" communicated well	81%
Staff "always" explained	63%
Yes, staff "did" give patients this information	89%
Yes, staff "did" give patients information about help after discharge	89%
Doctors "always" explained things so they could understand	76%
Doctors "always" listened carefully	80%
Doctors "always" treated them with courtesy and respect	87%
Patients who gave a rating of "9" or "10" (high)	79%
Staff "always" explained new medications	76%
Nurses "always" explained things so they could understand	77%
Nurses "always" listened carefully	79%
Nurses "always" treated them with courtesy and respect	88%
"Always" quiet at night	53%
"YES", patients would definitely recommend the hospital	83%
Staff "always" explained possible side effects	50%
Yes, staff "did" give patients information about possible symptoms	90%

Original Medicare doctor bills

$16,241

Medicare paid this office $16,241 for 107 people. Most of that is long return visits and Botox.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Sort by

Largest Original Medicare bills

Long return visit (40+ min)	50	$6,047	$99
Return visit (30+ min)	41	$2,921	$61
Long return visit (40+ min)	18	$2,683	$141
Return visit (30+ min)	25	$2,478	$95
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	16	$229	$13

Who their Medicare patients are

107 Original Medicare patients in 2024. Average age 74 · Women 66% · Also on Medicaid 30% · Health risk score 1.21. At or below the middle of the specialty; the typical physician assistant clinician is at 1.31.

Conditions among them: High blood pressure 75% · Coronary heart disease 51% · Diabetes 38% · Chronic kidney disease 30% · Cancer 20% · Atrial fibrillation 17% · Depression 16% · Heart failure 15% · Stroke 13%.

The office billed $68,408, Medicare allowed $22,487 and paid $16,241; for 199 services of 11 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Sort by

Original Medicare by year

2024	107	199	74	1.21	$68,408	$16,241
2023	142	251	75	1.22	$117,146	$22,642
2022	107	169	74	1.29	$73,563	$15,047
2021	88	156	73	1.31	$54,450	$15,668
2020	166	447	70	1.64	$48,456	$21,110
2019	262	1,218	69	1.61	$114,315	$52,771
2018	278	1,385	70	1.84	$146,988	$72,349
2017	321	2,194	71	1.87	$220,275	$104,115
2016	153	720	71	1.88	$54,654	$24,083
2014	77	223	72	2.59	$29,600	$13,289

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 3 services

Sort by

Original Medicare services billed in 2023

Long return visit (40+ min)	92	$14,292	$103
Return visit (30+ min)	58	$4,838	$70
New patient visit (60+ min)	17	$1,987	$117

2022: 4 services

Sort by

Original Medicare services billed in 2022

Long return visit (40+ min)	51	$6,566	$106
New patient visit (60+ min)	25	$3,219	$129
Return visit (30+ min)	34	$2,758	$75
Telephone medical discussion with physician, 11-20 minutes	12	$600	$43

2021: 3 services

Sort by

Original Medicare services billed in 2021

Long return visit (40+ min)	59	$9,590	$118
New patient visit (60+ min)	14	$2,169	$155
Return visit (30+ min)	22	$1,877	$78

2020: 7 services

Sort by

Original Medicare services billed in 2020

Return visit (30+ min)	71	$7,642	$78
Short return visit (20+ min)	67	$4,241	$54
Telephone medical discussion with physician, 11-20 minutes	54	$3,749	$58
Telephone medical discussion with physician, 5-10 minutes	21	$787	$36
Injection of drug or substance under skin or into muscle	23	$267	$11
Injection, triamcinolone acetonide, not otherwise specified, 10 mg	13	$65	None
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg	18	$28	None

2019: 13 services

Sort by

Original Medicare services billed in 2019

Short return visit (20+ min)	198	$23,558	$57
Return visit (30+ min)	123	$15,776	$83
Influenza vaccine, inactivated	23	$1,332	$58
Injection of drug or substance under skin or into muscle	50	$1,070	$14
Ultrasonic guidance for needle placement	19	$973	$46
Injection of trigger points, 1-2 muscles	15	$712	$44
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	41	$611	$14
Administration of influenza virus vaccine	30	$605	$20
Test to measure expiratory airflow and volume	14	$516	$30
Short return visit	12	$440	$37
Injection, triamcinolone acetonide, not otherwise specified, 10 mg	37	$239	None
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg	39	$79	None
Blood glucose (sugar) test performed by hand-held instrument	14	$45	$3

2018: 14 services

Sort by

Original Medicare services billed in 2018

Return visit (30+ min)	198	$37,069	$85
Short return visit (20+ min)	151	$14,112	$57
New patient visit (45+ min)	23	$2,955	$128
Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit	14	$2,393	$171
Injection of drug or substance under skin or into muscle	59	$1,789	$17
Influenza vaccine, inactivated	28	$1,487	$53
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	11	$1,293	$118
Aspiration and/or injection of fluid large joint using ultrasound guidance	14	$1,227	$72
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	65	$910	$13
Administration of influenza virus vaccine	30	$759	$25
Test to measure expiratory airflow and volume	17	$526	$31
Injection, triamcinolone acetonide, not otherwise specified, 10 mg	36	$246	None
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg	52	$143	None
Blood glucose (sugar) test performed by hand-held instrument	13	$51	$3

2017: 19 services

Sort by

Original Medicare services billed in 2017

Return visit (30+ min)	270	$59,983	$83
Long return visit (40+ min)	47	$6,482	$112
Short return visit (20+ min)	69	$4,736	$56
New patient visit (45+ min)	27	$3,295	$122
Injection of drug or substance under skin or into muscle	84	$3,109	$21
Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	16	$3,056	$191
Ultrasonic guidance for needle placement	39	$2,616	$48
Injection of trigger points, 3 or more muscles	37	$2,314	$48
Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit	12	$2,003	$167
New patient visit (60+ min)	11	$1,626	$148
Influenza vaccine, inactivated	30	$1,477	$49
Aspiration and/or injection of fluid large joint using ultrasound guidance	14	$1,347	$71
Test to measure expiratory airflow and volume	34	$1,077	$29
Administration of influenza virus vaccine	31	$964	$31
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	66	$945	$13
Injection, triamcinolone acetonide, not otherwise specified, 10 mg	66	$594	None
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg	73	$298	None
Hemoglobin a1c level	11	$144	$13
Blood glucose (sugar) test performed by hand-held instrument	15	$60	$3

2016: 8 services

Sort by

Original Medicare services billed in 2016

Return visit (30+ min)	122	$13,825	$79
Short return visit (20+ min)	24	$1,365	$55
Injection of trigger points, 3 or more muscles	15	$1,112	$48
Ultrasonic guidance for needle placement	15	$1,072	$47
Injection of drug or substance under skin or into muscle	20	$458	$20
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	17	$234	$13
Injection, triamcinolone acetonide, not otherwise specified, 10 mg	19	$172	None
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg	19	$80	None

2014: 4 services

Sort by

Original Medicare services billed in 2014

Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more	24	$4,913	$51
Return visit (30+ min)	20	$2,280	$81
Short return visit (20+ min)	35	$2,270	$55
Subsequent nursing facility care with moderate level of medical decision making, per day at least 30 minutes	20	$2,024	$67

Medicaid work

$14,037 in 2020

Medicaid paid $14,037 for 440 billed services this clinician did in 2020, up to 48 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

Sort by

Largest Medicaid services in 2020

Return visit (30+ min)	261	$9,727
Short return visit (20+ min)	179	$4,310

Sort by

Medicaid work by year

2020	440	2	48	$14,037
2019	980	4	75	$26,292
2018	998	7	64	$30,222

See the largest Medicaid services in earlier years

2019

Sort by

Largest Medicaid services in 2019

Short return visit (20+ min)	650	$15,855
Return visit (30+ min)	248	$9,167
Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular	69	$944
Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report	13	$325

2018

Sort by

Largest Medicaid services in 2018

Return visit (30+ min)	467	$18,371
Short return visit (20+ min)	386	$9,646
Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular	49	$878
Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, preservative and antibiotic free, 0.5 mL dosage, for intramuscular use	29	$720
Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report	13	$349
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg	26	$142
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid)	28	$117

Drugs they prescribed that Part D paid

$121,189

Pharmacies billed $121,189 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 0% of their Part D prescriptions (0 of 940) in 2024. At or below the middle of the specialty; the typical physician assistant clinician is at 1%.

824 generic and 116 brand-name prescriptions · $121,189 in drug cost.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Sort by

Largest Part D drug costs

Repatha Sureclick	60	$52,558	$876
Eliquis	25	$26,382	$1,055
Jardiance	11	$9,471	$861
Rosuvastatin	137	$3,505	$26
Ezetimibe	64	$2,661	$42

See all 17 drugs

Sort by

Every Part D drug this clinician prescribed

Repatha Sureclick	60	$52,558	$876
Eliquis	25	$26,382	$1,055
Jardiance	11	$9,471	$861
Rosuvastatin	137	$3,505	$26
Ezetimibe	64	$2,661	$42
Atorvastatin	110	$1,453	$13
Metoprolol	88	$1,200	$14
Losartan	82	$876	$11
Nebivolol	12	$840	$70
Amlodipine Besylate	95	$635	$7
Bumetanide	11	$328	$30
Carvedilol	21	$266	$13
Lisinopril	34	$242	$7
Spironolactone	16	$217	$14
Nitroglycerin	13	$189	$15
Hydrochlorothiazide	31	$141	$5
Metoprolol	14	$62	$4

Year by year

Sort by

Part D prescribing by year

2024	940	146	0% (0)	12%	$121,189
2023	746	137	0% (0)	12%	$81,990
2022	417	101	0% (0)	12%	$32,484
2021	497	129	0% (0)	None	$37,794
2020	1,079	155	2% (17)	18%	$108,819
2019	1,562	220	1% (16)	21%	$219,662
2018	1,686	223	3% (47)	21%	$206,757
2017	1,366	225	6% (81)	20%	$123,747
2016	2,233	405	57% (1,278)	None	$154,760
2015	2,078	315	62% (1,289)	None	$169,184
2014	579	188	59% (344)	None	$50,464

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 14 drugs

Sort by

Part D drugs prescribed in 2023

Eliquis	19	$19,520	$1,027
Repatha Sureclick	17	$14,176	$834
Praluent	24	$13,831	$576
Rosuvastatin	121	$3,846	$32
Atorvastatin	79	$1,706	$22
Amlodipine Besylate	112	$1,591	$14
Metoprolol	79	$1,373	$17
Ezetimibe	23	$1,264	$55
Losartan	49	$748	$15
Carvedilol	25	$381	$15
Lisinopril	29	$323	$11
Hydralazine	15	$307	$20
Hydrochlorothiazide	28	$181	$6
Metoprolol	14	$151	$11

2022: 7 drugs

Sort by

Part D drugs prescribed in 2022

Stiolto Respimat	12	$5,670	$473
Rosuvastatin	34	$1,042	$31
Atorvastatin	52	$783	$15
Amlodipine Besylate	70	$588	$8
Metoprolol	26	$571	$22
Losartan	31	$356	$11
Carvedilol	24	$232	$10

2021: 11 drugs

Sort by

Part D drugs prescribed in 2021

Stiolto Respimat	12	$5,541	$462
Atorvastatin	45	$755	$17
Amlodipine Besylate	61	$705	$12
Rosuvastatin	17	$505	$30
Metoprolol	28	$493	$18
Losartan	36	$433	$12
Levothyroxine	17	$294	$17
Hydrochlorothiazide	22	$227	$10
Lisinopril	12	$166	$14
Carvedilol	18	$164	$9
Metoprolol	12	$103	$9

2020: 24 drugs

Sort by

Part D drugs prescribed in 2020

Januvia	25	$13,409	$536
Linzess	18	$11,080	$616
Ranolazine Er	23	$4,499	$196
Bystolic	13	$2,059	$158
Prasugrel	12	$858	$71
Levothyroxine	29	$835	$29
Atorvastatin	66	$761	$12
Pregabalin	13	$686	$53
Ventolin Hfa	11	$643	$58
Metoprolol	39	$574	$15
Pantoprazole	29	$554	$19
Gabapentin	35	$540	$15
Losartan	38	$449	$12
Omeprazole	18	$449	$25
Amlodipine Besylate	63	$417	$7
Metformin	46	$322	$7
Hydrochlorothiazide	26	$251	$10
Lisinopril	32	$195	$6
Simvastatin	26	$190	$7
Carvedilol	19	$114	$6
Tamsulosin	13	$113	$9
Furosemide	15	$98	$7
Zolpidem	19	$95	$5
Metoprolol	11	$58	$5

2019: 39 drugs

Sort by

Part D drugs prescribed in 2019

Farxiga	17	$25,820	$1,519
Lantus	12	$22,777	$1,898
Entresto	23	$18,292	$795
Januvia	21	$14,995	$714
Ranexa	11	$14,946	$1,359
Breo Ellipta	12	$4,979	$415
Ranolazine Er	13	$3,929	$302
Ventolin Hfa	25	$1,604	$64
Levothyroxine	56	$1,474	$26
Metoprolol	56	$1,380	$25
Atorvastatin	79	$1,139	$14
Gabapentin	53	$992	$19
Amlodipine Besylate	92	$657	$7
Potassium Chloride	18	$601	$33
Losartan	60	$475	$8
Pantoprazole	20	$406	$20
Pravastatin	11	$386	$35
Metformin	52	$382	$7
Isosorbide Mononitrate Er	24	$369	$15
Omeprazole	23	$307	$13
Carvedilol	29	$295	$10
Furosemide	27	$260	$10
Hydrochlorothiazide	34	$234	$7
Simvastatin	41	$228	$6
Lisinopril	28	$225	$8
Hydroxyzine	14	$204	$15
Zolpidem	24	$200	$8
Glipizide	23	$188	$8
Metoprolol	29	$176	$6
Meclizine	25	$169	$7
Alendronate	11	$167	$15
Ibuprofen	16	$130	$8
Metformin Hcl Er	12	$128	$11
Naproxen	18	$114	$6
Clonidine	12	$107	$9
Trazodone	16	$103	$6
Azithromycin	12	$95	$8
Atenolol	11	$91	$8
Lorazepam	15	$86	$6

2018: 39 drugs

Sort by

Part D drugs prescribed in 2018

Ranexa	35	$32,606	$932
Entresto	21	$16,542	$788
Lantus	12	$13,050	$1,087
Lantus Solostar	14	$7,944	$567
Breo Ellipta	11	$4,504	$409
Ventolin Hfa	24	$1,611	$67
Atorvastatin	61	$1,161	$19
Levothyroxine	36	$1,048	$29
Metoprolol	46	$1,016	$22
Gabapentin	61	$715	$12
Amlodipine Besylate	101	$611	$6
Simvastatin	71	$487	$7
Losartan	55	$481	$9
Pantoprazole	33	$468	$14
Metformin	55	$445	$8
Allopurinol	18	$427	$24
Omeprazole	28	$329	$12
Pravastatin	12	$314	$26
Hydrocodone-Acetaminophen	26	$308	$12
Naproxen	29	$241	$8
Lisinopril	44	$230	$5
Losartan-Hydrochlorothiazide	16	$209	$13
Oxybutynin Chloride	12	$188	$16
Metoprolol	34	$187	$6
Hydrochlorothiazide	31	$186	$6
Potassium Chloride	13	$179	$14
Furosemide	32	$156	$5
Prednisone	12	$154	$13
Meclizine	26	$151	$6
Zolpidem	19	$140	$7
Alendronate	12	$130	$11
Glipizide	19	$118	$6
Lorazepam	24	$115	$5
Carvedilol	22	$114	$5
Hydralazine	11	$113	$10
Atenolol	18	$110	$6
Sertraline	15	$105	$7
Trazodone	14	$92	$7
Clonidine	11	$74	$7

2017: 32 drugs

Sort by

Part D drugs prescribed in 2017

Linzess	17	$12,896	$759
Ranexa	20	$10,967	$548
Anoro Ellipta	11	$3,984	$362
Humalog	11	$2,962	$269
Metoprolol	36	$996	$28
Levothyroxine	30	$905	$30
Ventolin Hfa	15	$800	$53
Atorvastatin	27	$587	$22
Fenofibrate	12	$510	$43
Amlodipine Besylate	80	$470	$6
Losartan	61	$438	$7
Hydrocodone-Acetaminophen	47	$431	$9
Gabapentin	42	$396	$9
Simvastatin	56	$394	$7
Metformin	47	$391	$8
Allopurinol	17	$343	$20
Pantoprazole	15	$277	$18
Lisinopril	33	$202	$6
Potassium Chloride	15	$186	$12
Hydrochlorothiazide	36	$182	$5
Lorazepam	44	$182	$4
Zolpidem	30	$170	$6
Carvedilol	22	$162	$7
Omeprazole	14	$159	$11
Clopidogrel	12	$154	$13
Glipizide	21	$134	$6
Naproxen	23	$134	$6
Prednisone	13	$107	$8
Metoprolol	13	$86	$7
Furosemide	20	$86	$4
Meclizine	11	$77	$7
Azithromycin	11	$54	$5

2016: 30 drugs

Sort by

Part D drugs prescribed in 2016

Oxycontin	81	$36,170	$447
Lyrica	60	$32,438	$541
Hydrocodone-Acetaminophen	528	$15,389	$29
Morphine Sulfate Er	132	$10,282	$78
Oxycodone-Acetaminophen	127	$9,156	$72
Lidocaine	30	$6,066	$202
Fentanyl	74	$5,488	$74
Gabapentin	245	$4,769	$19
Oxycodone	113	$3,453	$31
Voltaren	28	$3,143	$112
Diclofenac	18	$1,415	$79
Tizanidine	66	$1,320	$20
Hydromorphone	49	$1,259	$26
Methadone	50	$1,111	$22
Zolpidem	39	$730	$19
Duloxetine	20	$590	$29
Tramadol	53	$519	$10
Diclofenac Sodium Er	15	$307	$20
Morphine Sulfate	14	$306	$22
Naproxen	36	$296	$8
Alprazolam	23	$209	$9
Carisoprodol	27	$194	$7
Lorazepam	19	$179	$9
Tramadol Hcl-Acetaminophen	14	$151	$11
Acetaminophen-Codeine	16	$148	$9
Cyclobenzaprine	21	$140	$7
Ibuprofen	19	$137	$7
Diazepam	24	$117	$5
Topiramate	11	$65	$6
Meloxicam	12	$64	$5

2015: 28 drugs

Sort by

Part D drugs prescribed in 2015

Oxycontin	128	$64,999	$508
Lyrica	60	$22,711	$379
Morphine Sulfate Er	132	$14,264	$108
Hydrocodone-Acetaminophen	475	$13,725	$29
Fentanyl	96	$11,423	$119
Oxycodone	152	$6,909	$45
Lidocaine	33	$6,281	$190
Oxycodone-Acetaminophen	97	$5,553	$57
Gabapentin	204	$4,191	$21
Voltaren	23	$1,618	$70
Duloxetine	15	$795	$53
Hydromorphone	47	$735	$16
Methadone	27	$681	$25
Cyclobenzaprine	47	$660	$14
Lorazepam	24	$535	$22
Tramadol	69	$513	$7
Carisoprodol	37	$486	$13
Tizanidine	25	$429	$17
Ibuprofen	20	$281	$14
Morphine Sulfate	15	$272	$18
Omeprazole	33	$247	$7
Naproxen	37	$236	$6
Baclofen	23	$233	$10
Diazepam	31	$170	$5
Hydroxyzine	12	$170	$14
Zolpidem	43	$161	$4
Acetaminophen-Codeine	16	$150	$9
Alprazolam	13	$59	$5

2014: 13 drugs

Sort by

Part D drugs prescribed in 2014

Oxycontin	22	$8,992	$409
Morphine Sulfate Er	49	$5,573	$114
Hydrocodone-Acetaminophen	129	$3,576	$28
Fentanyl	29	$3,289	$113
Oxycodone	35	$1,674	$48
Oxycodone-Acetaminophen	15	$1,425	$95
Gabapentin	48	$1,018	$21
Methadone	15	$202	$13
Morphine Sulfate	15	$187	$12
Hydromorphone	11	$177	$16
Omeprazole	15	$154	$10
Baclofen	11	$142	$13
Zolpidem	11	$74	$7

Money from drug and device companies

$565 in 2025

Sort by

Industry payments by year

2025	4	4	None	$565
2024	2	2	None	$106
2023	2	2	None	$207
2022	1	1	None	$18
2021	3	6	None	$115

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Sort by

Payments by company

Heartflow	Ffrct	$192	1 payment Meals for Ffrct · 2025-10-23 · $192
Esperion Therapeutics	Nexletol	$131	1 payment Meals for Nexletol · 2025-10-09 · $131
Novartis Pharmaceuticals	Leqvio	$125	1 payment Meals for Leqvio · 2025-08-28 · $125
Novo Nordisk	None	$117	1 payment Meals · 2025-04-29 · $117

See all 4 published payments

Sort by

Every published payment

Heartflow	Meals · 2025-10-23	Ffrct	$192
Esperion Therapeutics	Meals · 2025-10-09	Nexletol	$131
Novartis Pharmaceuticals	Meals · 2025-08-28	Leqvio	$125
Novo Nordisk	Meals · 2025-04-29	None	$117

See earlier years (2024, 2023, 2022, 2021)

2024: $106

Sort by

Payments by company in 2024

Novo Nordisk	None	$86	1 payment Meals · 2024-03-05 · $86
Esperion Therapeutics	Nexletol	$20	1 payment Meals for Nexletol · 2024-10-02 · $20

2023: $207

Sort by

Payments by company in 2023

Amgen	Repatha	$115	1 payment Meals for Repatha · 2023-03-14 · $115
Novo Nordisk	None	$92	1 payment Meals · 2023-09-18 · $92

2022: $18

Sort by

Payments by company in 2022

Novartis Pharmaceuticals	Leqvio	$18	1 payment Meals for Leqvio · 2022-10-25 · $18

2021: $115

Sort by

Payments by company in 2021

Boston Scientific	Watchman	$59	3 payments Meals for Watchman · 2021-05-14 · $25 Meals for Watchman · 2021-03-26 · $14 Meals for Watchman · 2021-02-13 · $19
Electromed	Smartvest	$36	2 payments Meals for Smartvest · 2021-03-29 · $18 Meals for Smartvest · 2021-02-01 · $18
Salix Pharmaceuticals a division of Bausch Health US	Xifaxan	$20	1 payment Meals for Xifaxan · 2021-09-08 · $20

Checkups this office reported

Medicare did not publish checkup rates for this clinician.

Medicare’s overall office score: 76.5 / 100; Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.

Professional record

NPI: 1750704482
Licence: CA PA51358
Trained: University of New Mexico School of Medicine, 2013
Group: Stanford Health Care
Video visits: Lists video visits
Gender: Female

More record details

Sole proprietor: No
Taxonomy: Physician assistant (363A00000X); Physician assistant, medical (363AM0700X)
Mailing address: 300 Pasteur Dr, Stanford, CA, 94305
NPI first listed: 2014-01-31
NPI last updated: 2025-12-23
NPI record certified: 2025-12-23

This is when the NPI record was last certified, not a medical board exam.

Extra NPI addresses: 27171 Calaroga Ave Ste 1-3, Hayward, CA, 94545